Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab-Reference-Cited by-同舟云学术

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab

Published:2020-09-02 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Kos Igor,Balensiefer Benedikt,Roth Sophie,Ahlgrimm Manfred,Sester Martina,Schmidt Tina,Thurner Lorenz,Bewarder Moritz,Bals Robert,Lammert Frank,Stilgenbauer Stephan,Kaddu-Mulindwa Dominic

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference17 articles.

1. COVID-19 in persons with haematological cancers;He;Leukemia.,2020

2. Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG);Forstpointner;Blood.,2006

3. Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China;He;Respir Med.,2020

4. How to obtain a nasopharyngeal swab specimen;Marty;N Engl J Med.,2020

5. Temporal dynamics in viral shedding and transmissibility of COVID-19;He;Nat Med.,2020

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing immunity: Immunomodulatory therapies in COVID-19;World Journal of Virology;2024-06-25

2. Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy;European Journal of Clinical Microbiology & Infectious Diseases;2024-02-15

3. Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study;Journal of Korean Medical Science;2024

4. SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing;BMJ Case Reports;2023-12

5. Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy;Internal Medicine;2023-09-01